PortfoliosLab logo
Meihua International Medical Technologies Co Ltd (...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG5966G1082

IPO Date

Feb 16, 2022

Highlights

Market Cap

$9.89M

EPS (TTM)

$0.40

PE Ratio

0.78

Total Revenue (TTM)

$74.24M

Gross Profit (TTM)

$25.60M

EBITDA (TTM)

$12.49M

Year Range

$0.25 - $1.47

Short %

1.77%

Short Ratio

0.91

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Meihua International Medical Technologies Co Ltd (MHUA) returned -10.17% year-to-date (YTD) and -56.39% over the past 12 months.


MHUA

YTD

-10.17%

1M

-3.13%

6M

-41.28%

1Y

-56.39%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of MHUA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-7.74%3.02%2.26%-18.01%12.73%-10.17%
2024-32.43%-29.50%4.68%-6.64%-4.95%30.08%19.73%-10.37%11.57%-33.33%-22.34%-34.65%-76.68%
202379.83%128.21%-80.90%-44.53%-23.33%3.26%-5.09%3.51%-36.79%-1.41%4.30%-18.68%-82.13%
2022-36.38%14.36%-11.70%-30.72%-7.83%-10.57%-19.83%57.89%28.33%74.42%-38.35%-35.91%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MHUA is 23, meaning it’s performing worse than 77% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of MHUA is 2323
Overall Rank
The Sharpe Ratio Rank of MHUA is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of MHUA is 2929
Sortino Ratio Rank
The Omega Ratio Rank of MHUA is 2828
Omega Ratio Rank
The Calmar Ratio Rank of MHUA is 1414
Calmar Ratio Rank
The Martin Ratio Rank of MHUA is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Meihua International Medical Technologies Co Ltd (MHUA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Meihua International Medical Technologies Co Ltd Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.52
  • All Time: -0.53

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Meihua International Medical Technologies Co Ltd compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Meihua International Medical Technologies Co Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Meihua International Medical Technologies Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Meihua International Medical Technologies Co Ltd was 99.32%, occurring on May 2, 2025. The portfolio has not yet recovered.

The current Meihua International Medical Technologies Co Ltd drawdown is 99.21%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.32%Feb 22, 2023551May 2, 2025
-79.87%Feb 17, 2022109Jul 26, 202288Nov 29, 2022197
-47.44%Nov 30, 202221Dec 29, 202221Jan 31, 202342
-19.75%Feb 10, 20231Feb 10, 20234Feb 16, 20235
-5.01%Feb 2, 20233Feb 6, 20231Feb 7, 20234

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Meihua International Medical Technologies Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Meihua International Medical Technologies Co Ltd, comparing actual results with analytics estimates.


0.000.200.400.600.80October2021AprilJulyOctober2022AprilJulyOctober2023
0.27
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how Meihua International Medical Technologies Co Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for MHUA, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/E ratio of 0.8. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MHUA relative to other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for MHUA in comparison with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/B value of 0.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items